Comprehensive Solutions for Heart Failure Management
Breakthrough technologies with proven clinical outcomes
Approximately 26 million people live with HF worldwide,1 and the estimated global cost is $108 billion annually.2 With the complexity and rise of heart failure, the Heart Failure Association of the European Society of Cardiology aims to make the prevention and management of heart failure a global health priority.
At Abbott, we dedicate our efforts to providing you with the broadest scope of innovative and outcome-driven solutions to manage the clinical and economic burden of heart failure and hypertension. The benefits of frequent insight and early intervention that our technologies can give you are matched only by our ability to increase efficacy while decreasing the economic cost associated with cardiovascular care.